反应 #742310
ord-ec0ae89cfd5342b1acb90abbd8a5df18
反应方程式
1-{(R)-1-[9-[(2R,3R,4S R)-3,4-dihydroxy-5-(2H-tetrazol-5-yl)-tetrahydro-furan-2-yl]-6-(2,2-diphenyl-ethylamino)-9H-purin-2-yl]-pyrrolidin-3-yl}-3-pyridin-3-yl-urea
potassium carbonate
DMF
→
titled compound
1-{(R)-1-[9-{(2R,3R,4S,5R)-3,4-Dihydroxy-5-[2-(2-hydroxy-ethyl)-2H-tetrazol-5-yl]-tetrahydro-furan-2-yl}-6-(2,2-diphenyl-ethylamino)-9H-purin-2-yl]-pyrrolidin-3-yl}-3-pyridin-3-yl-urea
反应物
试剂
无
反应条件
详细条件
See reaction.notes.procedure_details.
后处理
- 1过滤The mixture is then filtered
- 2浓缩the filtrate is concentrated in vacuo
- 3其他Purification of the crude product by C-18 reverse phase column chromatography
- 4洗涤eluting with acetonitrile
实验过程
A solution of 1-{(R)-1-[9-[(2R,3R,4S R)-3,4-dihydroxy-5-(2H-tetrazol-5-yl)-tetrahydro-furan-2-yl]-6-(2,2-diphenyl-ethylamino)-9H-purin-2-yl]-pyrrolidin-3-yl}-3-pyridin-3-yl-urea in DMF is treated with potassium carbonate followed by 3-bromoethanol and stirred at RT for 18 hours. The mixture is then filtered and the filtrate is concentrated in vacuo. Purification of the crude product by C-18 reverse phase column chromatography eluting with acetonitrile:water (0.1% TFA) (gradient 0-100% acetonitrile) to affords the titled compound.